These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38841494)
1. Development of raft-forming liquid formulations loaded with ginger extract-solid dispersion for treatment of gastric ulceration. Matchimabura N; Praparatana R; Issarachot O; Oungbho K; Wiwattanapatapee R Heliyon; 2024 Jun; 10(11):e31803. PubMed ID: 38841494 [TBL] [Abstract][Full Text] [Related]
2. Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers. Bunlung S; Nualnoi T; Issarachot O; Wiwattanapatapee R Saudi Pharm J; 2021 Oct; 29(10):1143-1154. PubMed ID: 34703368 [TBL] [Abstract][Full Text] [Related]
3. Raft-forming gastro-retentive formulations based on Centella asiatica extract-solid dispersions for gastric ulcer treatment. Wannasarit S; Mahattanadul S; Issarachot O; Puttarak P; Wiwattanapatapee R Eur J Pharm Sci; 2020 Feb; 143():105204. PubMed ID: 31870812 [TBL] [Abstract][Full Text] [Related]
4. Development of starch/chitosan expandable films as a gastroretentive carrier for ginger extract-loaded solid dispersion. Kaewkroek K; Petchsomrit A; Wira Septama A; Wiwattanapatapee R Saudi Pharm J; 2022 Feb; 30(2):120-131. PubMed ID: 35528854 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment. Kerdsakundee N; Mahattanadul S; Wiwattanapatapee R Eur J Pharm Biopharm; 2015 Aug; 94():513-20. PubMed ID: 26143367 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous Delivery of Curcumin and Resveratrol via In Situ Gelling, Raft-Forming, Gastroretentive Formulations. Siripruekpong W; Praparatana R; Issarachot O; Wiwattanapatapee R Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794303 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a gastro-retentive delivery system for improved antiulcer activity of ginger extract (Zingiber officinale). Kumar Singh P; Pal Kaur I J Drug Target; 2011 Nov; 19(9):741-51. PubMed ID: 21401390 [TBL] [Abstract][Full Text] [Related]
8. Superporous hydrogels based on blends of chitosan and polyvinyl alcohol as a carrier for enhanced gastric delivery of resveratrol. Issarachot O; Bunlung S; Kaewkroek K; Wiwattanapatapee R Saudi Pharm J; 2023 Mar; 31(3):335-347. PubMed ID: 37026050 [TBL] [Abstract][Full Text] [Related]
10. Development of Oral In Situ Gelling Liquid Formulations of Garcinia Extract for Treating Obesity. Fungfoung K; Praparatana R; Issarachot O; Wiwattanapatapee R Gels; 2023 Aug; 9(8):. PubMed ID: 37623115 [TBL] [Abstract][Full Text] [Related]
11. Improved gastric residence time of famotidine by raft-forming drug delivery system using DOE. Munusamy R; Shanmugasundharam S Int J Immunopathol Pharmacol; 2024; 38():3946320241249429. PubMed ID: 38721971 [TBL] [Abstract][Full Text] [Related]
12. Foldable/Expandable Gastro-retentive Films Based on Starch and Chitosan as a Carrier For Prolonged Release of Resveratrol. Boontawee R; Issarachot O; Kaewkroek K; Wiwattanapatapee R Curr Pharm Biotechnol; 2022; 23(7):1009-1018. PubMed ID: 34132179 [TBL] [Abstract][Full Text] [Related]
13. Ginger Extract-Loaded Solid Dispersion System with Enhanced Oral Absorption and Antihypothermic Action. Sato H; Ogino M; Yakushiji K; Suzuki H; Shiokawa KI; Kikuchi H; Seto Y; Onoue S J Agric Food Chem; 2017 Feb; 65(7):1365-1370. PubMed ID: 28132501 [TBL] [Abstract][Full Text] [Related]
14. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Mandel KG; Daggy BP; Brodie DA; Jacoby HI Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650 [TBL] [Abstract][Full Text] [Related]
15. A novel in vitro approach to investigate the effect of food intake on release profile of valsartan in solid dispersion-floating gel in-situ delivery system. Himawan A; Djide NJN; Mardikasari SA; Utami RN; Arjuna A; Donnelly RF; Permana AD Eur J Pharm Sci; 2022 Jan; 168():106057. PubMed ID: 34743031 [TBL] [Abstract][Full Text] [Related]
16. Characterization of raft-forming alginate suspensions formed in HCl or model food systems at varying pH levels to better simulate gastric postprandial conditions. Keppler S; Mannara G; Marra F; Bornhorst GM Drug Dev Ind Pharm; 2021 Jul; 47(7):1079-1089. PubMed ID: 34254865 [TBL] [Abstract][Full Text] [Related]
17. Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 3 Hani U; Rahamathulla M; Osmani RAM; Begum MY; Wahab S; Ghazwani M; Fatease AA; Alamri AH; Gowda DV; Alqahtani A Polymers (Basel); 2022 Jun; 14(13):. PubMed ID: 35808569 [TBL] [Abstract][Full Text] [Related]
18. Oral co-polymeric raft-forming nano gels for targeted empagliflozin delivery against stomach cancer (SGC7901). Alhakamy NA; Abdullah S; Md S; Ansari AR; Bhattamisra SK; Ibrahim IM; Alahdal H; Altamimi AA; Shaik RA Heliyon; 2024 Jul; 10(13):e34074. PubMed ID: 39071709 [TBL] [Abstract][Full Text] [Related]
19. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl. El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220 [TBL] [Abstract][Full Text] [Related]
20. Formulation, optimization, and evaluation of raft-forming formulations containing Nizatidine. Darwish MKM; Abu El-Enin ASM; Mohammed KHA Drug Dev Ind Pharm; 2019 Apr; 45(4):651-663. PubMed ID: 30638411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]